The clinical primary success rate was 60%. In-hospital mortality was 0.7%, 2.8% of patients sustained a procedural myocardial infarction, and 1.3% of patients underwent emergency bypass surgery. After a follow-up period of 5 years, 74% of patients were alive, and 26% were alive and event-free (no myocardial infarction, no repeat bypass surgery or repeat angioplasty).
gioplasty of 11 saphenous vein bypass graft was reviewed. In 46% of patients single graft angioplasty was attempted, and in 64% of patients sequential graft angioplasty was attempted.
The clinical primary success rate was 60%. In-hospital mortality was 0.7%, 2.8% of patients sustained a procedural myocardial infarction, and 1.3% of patients underwent emergency bypass surgery. After a follow-up period of 5 years, 74% of patients were alive, and 26% were alive and event-free (no myocardial infarction, no repeat bypass surgery or repeat angioplasty).
In patients in whom the initial angioplasty attempt was unsuccessful, only 3% were event-free at 5 years, versus 27% of successfully dilated patients. The time interval between the angioplasty attempt and previous surgery was a significant predictor for S-year event-free survival. The event-free survival rates for patients who had bypass surgery 1 year before, between 1 and 5 years, and 5 years before angioplasty, were 4526
and 19%, respectively.
Less than one-third of patients with previous bypass surgery who had angioplasty of the graft remained event-free after 5 years. In patients needing angioplasty within 1 year after bypass surgery, better long-term results were achieved.
(AmJ Cardiol 1991;67:361-366) R ecurrence of angina pectoris after aortocoronary bypass surgery in patients with coronary artery disease is either caused by progression of disease in the native coronary artery or by the development of new narrowings in 21 bypass graft. Because of the increased morbidity and mortality of coronary reoperations, it is not surprising that percutaneous transluminal balloon angioplasty has been attempted in such patients to prevent a reoperation. It has been demonstrated1-9 that angioplasty can be successfully performed in paltients with a hemodynamically significant stenosis in a venous coronary bypass graft. Little is known about the long-term outcome after angioplasty.8, 10 In this study, we evaluated the long-term clinical effects of balloon angioplasty in venous bypass grafts in all 454 patients who had undergone such a procedure in The Netherlands between April 1980 (when the first coronary angioplasty procedure was performed) and January 1989. During this time period, a total of 19,994 coronary angioplasty procedures were performed in the country, of which the 454 patients represent 2.7%.
METHODS
Between April 1980 and January 1989,454 patients underwent angioplasty of at least 1 stenosis of >50% diameter in 21 saphenous vein bypass graft. Two hundred and sixty-four of 454 patients (58.1%) underwent an angioplasty either of the bypass graft and 2 1 native vessel (38 patients, 14.4%) or of the bypass graft alone (226 patients, 85.6%). There were 368 men (81%) and 86 women (19%) aged 34 to 78 years (mean f standard deviation 60 f 8.4). The number of diseased vessels was known for 200 of the 454 patients (44.1%). One-vessel disease was reported in 15 of 200 patients (7.5%), 2-vessel disease in 36 patients (18%) and 3-vessel disease in 149 patients (74.5%). In 46% of patients 21 stenoses in 21 single graft were dilated, and in 54% of patients 11 stenoses in a sequential or jump graft were dilated. In the patients who underwent single graft angioplasty, dilatation was attempted in 69% in grafts to the left anterior descending artery, in 21% in grafts to the right coronary artery and in 10% in grafts to the circumflex artery. The interval between coronary artery bypass surgery and balloon dilatation (or "graft age") ranged from 6 months to 17 years (mean age 5.7 f 3.8 years) (Figure 1) .
Primary success was defined as a reduction of the diameter stenosis to <50%, without the occurrence of an acute myocardial infarction, emergency bypass surgery or death, during the hospital stay of the patients. Acute myocardial infarction was defined as the occurrence of new Q waves on the electrocardiogram 130 ms or an increase in creatine phosphokinase to >3 times normal. Aortocoronary bypass surgery was considered to be an emergency when the patient was immediately transferred from the cardiac catheterization laboratory to the operating room.
Follow-up data were first obtained by means of a letter to the Civil Registration Service to establish survival status. If the patients were alive, they were interviewed by telephone, written questionnaires or outpatient clinic visits. The following events were considered as clinical end points: death, acute myocardial infaro tion, reoperation and redilatation.
All data are presented as mean f 1 standard deviation. Life tables were actuarially calculated according to the Kaplan-Meier method. The generalized Wilcoxon test was performed to detect differences between the subgroups. A p value <0.05 was considered statistically significant.
RESULTS
The primary success rate was 90%. In-hospital mortality was 0.7%. In 2.8% of patients there was evidence of a procedural acute myocardial infarction. In 1.3% of patients emergency coronary artery bypass surgery was performed.
Actuarial survival for the entire group was 74% (f3.4%) at 5 years ( Figure 2 ) and 63% (58%) at 8 years. However, in patients with initial unsuccessful graft angioplasty, 58% were alive at 5 years versus 78% of patients in whom graft angioplasty was successful (p <O.OOl) (Figure 3) .
After a follow-up period of 5 years, 58% of patients were alive and did not sustain a myocardial infarction. Thirty-four percent were alive, had no evidence of a myocardial infarction, and did not undergo repeat bypass surgery. After these 5 years 26% of patients Months FIGURE 2. After the follow-up period of 5 years, the cumulative probability of survival without any cardiac event (death, myocardial infarction, repeat bypass surgery and repsat angioplasty) was 26% (+3.3%) for all 464 patients. AMI = acute myocardiil infarction; reCABG = repeat coronary artery bypass grafting; rePlCA = repeat percutaneous transluminal coronary angioplasty.
(~3.3%) were alive and event-free. When only death, myocardial infarction and reoperation were considered as clinical end points, 34% of patients were alive and event-free after 5 years ( Figure 2) .
In patients in whom the initial graft angioplasty attempt was unsuccessful, only 3% were event-free at 5 years, versus 27% event-free patients in whom initial graft angioplasty was successful (p <O.OOOl) ( Figure  4 ). When grouped by graft age (intervals between bypass surgery and angioplasty <l year, between 1 and 5 years, and 15 years), there were statistically significant differences in 5-year event-free survival rates, namely 45% for patients who underwent angioplasty within 1 year after bypass surgery, in contrast to 25 and 19% for patients with grafts that had been implanted between 1 and 5 years, and >5 years before angioplasty, respectively (p <O.OOS) ( Figure 5 ). In this large collected angioplasty experience, only 2.7% of procedures included vein graft dilatation. Many contemporary series have a larger number of patients with graft dilatation. However, our reported incidence of 2.7% is a cumulative number and does not reflect the current percentage of patients undergoing graft angioplasty in The Netherlands, which was 4.1% in 1988. In 1988 the percentage of patients with previous bypass surgery undergoing angioplasty of the graft or > 1 more native vessel, or both, was 10.3%.
Furthermore, between 1980 and 1989 there has been a progressive recruitment of centers. The number of catheterization laboratories performing angioplasty in the country increased from 5 to 12. In addition, the expansion of the indication of graft angioplasty has been a slowly evolving phenomenon, which is also shown by the high incidence of bypass operations in The Netherlands.
Recurrence of angina after coronary artery bypass grafting remains a major clinical problem. Failure of aortocoronary saphenous vein bypass grafts is generally the result of either vein graft stenosis or progressive ath-FIGURE 3. The cumulative probability of S-year survival grouped by success. In patients in whom graft angioplasty had been unsuccessful, the probability of survival was significantly lower (58%) than in those in whom graft angioplasty had been successful (78%) (p <O.ool). FIGURE 4 . The cumulative probability of S-year event-free survival grouped by success. In patients in whom the initial graft angioplasty attempt had been unsuccessful, the chance of remaining event-free for the first 5 years afler the procedure was as low as 3%, compared with 27% for those in whom graft angioplasty had been successful (p <O.Gwl). Plaques in vein grafts resemble those in native coronary arteries and are generally soft and friable rather than densely fibrotic or calcific. Furthermore, because vein grafts tend to be larger than the native coronary arteries to which they are anastomosed, and because vein graft atherosclerosis often occurs in aneurysmally dilated segments, the plaques are generally quite large relative to those in native coronary arteries. Accordingly, atherosclerotic plaques in vein grafts seem particularly vulnerable to disruption and to embolization of relatively large fragments.
Although coronary artery bypass surgery using internal mammary artery grafts gives much better longterm graft patency rates,7-gJ6 vein grafts will continue to be utilized in a majority of surgical candidates with multivessel coronary artery disease, because not all vessels can be bypassed using internal mammary conduits.
Reoperation is technically more complicated to perform and is generally associated with a higher morbidity and mortality than a primary operation, and achieves symptomatic relief in only 60 to 70% of patients, compared with the 80 to 90% success rate after primary operations. The perioperative myocardial infarction rate varies among surgical groups from 2.0 to 11.5%. The mortality rate after repeat bypass surgery varies from 1.2 to 12.5%, and the incidence of reoperation for bleeding ranges from 3.6 to 10.2%.17m23
Angioplasty of a saphenous vein bypass graft was first performed in 1978 by Ford.24 Since then a number of publications have shown the feasibility of this technique, with an overall success rate of 87% (Table I) . Almost the same success rate was seen in our combined Dutch series. These rather high success rates probably reflect careful patient selection. Long midgraft lesions with highly irregular borders were usually avoided because of the risk of distal embolization from detached material within the grafts, but our angiographic data are insufficient to further detail the angiographic appearance of the lesions before percutaneous transluminal coronary angioplasty.
After a follow-up period of 5 years, 74% of 454 patients were alive, and only 26% of patients were alive and event-free. The number of diseased vessels was known for 44.1% of patients, so we could not ascertain the presence of multivessel disease as a factor leading to late events and reinterventions in the follow-up of these patients. Since, in this survey type of investigation, the reason for late events or repeat angioplasty or repeat bypass surgery is not available, it is difficult to speculate on the physiopathologic mechanism responsible for these follow-up events. We can not be certain if graft restenosis plays a major role in the high incidence of late events. However, the interval between coronary artery bypass surgery and angioplasty was known in all our patients (Figure 1 ). There were statistically significant (p <0.05) differences in event-free survival rates after a follow-up period of 5 years among patients who underwent bypass surgery within 1 year before angioplasty, between 1 and 5 years, and >5 years before angioplasty. Event-free survival was reported in 45, 25, and 19% of patients, respectively. This finding is in agreement with previously published data1-3,7-9,12 that suggest that anastomotic lesions respond better to angioplasty than lesions that occur later (midgraft). The manner in which balloon angioplasty relieves obstructions in vein grafts appears to be similar to that described for native coronary arteries and is characterized primarily by intima1 tears and plaque disruption. Within the first postoperative month, balloon angioplasty may be beneficial to relieve stenoses, particularly at distal anastomosis sites. Angioplasty of aortocoronary saphenous vein bypass grafts >l year of age can be performed with the realization that involvement by friable atherosclerosis is likely and that atheroembolization represents a risk. 25, 26 Eventually, the higher risk of reoperation will make the use of less aggressive forms of therapy more attractive. Angioplasty of the venous conduits, of the native vessels themselves and alternative forms of nonsurgical revascularization such as atherectomy, stenting and laser (balloon) angioplasty may obviate repeat bypass surgery in some patients. 27,28 However, within the limits of our study, we have not been able to look at the results of angioplasty of native coronary arteries in patients who again become symptomatic after venous bypass graft procedures. From published reports it seems that this technique also has its limitations.1~3~10, 12 Our data demonstrate that 74% of patients who undergo angioplasty of a stenosis in a venous graft survive 5 years after the angioplasty procedure, and that only 26% remain free of any major event. However, in patients needing angioplasty within 1 year after bypass surgery, better long-term results can be achieved. Finally, angioplasty of a venous graft stenosis may be an alternative to reoperation in some patients with previous coronary artery bypass surgery.
It is the inherent limitation of this type of epidemiologic historical survey, that, although it provides the clinical investigator with large numbers, the nonprospective nature of this investigation does not permit one to identify the factors that may improve patient selection.
